Aminomalonamide-13C3
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Aminomalonamide-13C3 Product Information
Aminomalonamide-13C3 is listed under Stable Isotope Reagent and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103820.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Aminomalonamide-13C3
CAT No.
CS-T-103820
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
13C3H7N3O2
Molecular Weight
120.09
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Aminomalonamide-13C3 is supplied with detailed characterization data compliant with regulatory guideline. Aminomalonamide-13C3 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
Aminomalonamide-13C3 is an intermediate in the synthesis of Favipiravir-13C3 (F103352), which is the isotope labelled analog of Favipiravir. Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product.
Synonyms
Aminomalonamide-13C3
Application Notes
Aminomalonamide-13C3 is an intermediate in the synthesis of Favipiravir-13C3 (F103352), which is the isotope labelled analog of Favipiravir. Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.